The effects of antiviral therapy on the distribution of herpes simplex virus type 1 to ganglionic neurons and its consequences during, immediately following and several months after treatment

Journal of General Virology

Volumn 81, Issue 10, 2000, Pages 2385-2396

  Thackray, A M ^a   Field, H J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BETA GALACTOSIDASE; FAMCICLOVIR; GENE PRODUCT; VALACICLOVIR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL THERAPY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; EXPLANT; FEMALE; GENE EXPRESSION; HERPES SIMPLEX VIRUS 1; IMMEDIATE EARLY GENE; IN SITU HYBRIDIZATION; INOCULATION; MOUSE; NERVE CELL; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SENSORY GANGLION; VIRUS CULTURE; VIRUS INFECTION; VIRUS LATENCY; VIRUS PATHOGENESIS; VIRUS RECOMBINANT;

ANIMALIA; DNA VIRUSES; HERPES; HUMAN HERPESVIRUS 1; MURINAE;

EID: 0033785525     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-81-10-2385     Document Type: Article

References (24)

1. Intranuclear foci containing low abundance herpes simplex virus latency-associated transcripts visualized by non-isotopic in situ hybridization
2. Comparative activity of penciclovir and acyclovir against herpes simplex virus type 2 in cell culture
3. Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture
4. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus
5. Reactivation of latent herpes simplex virus from explanted dorsal root ganglia
6. Neurons containing latency-associated transcripts are numerous and widespread in dorsal root ganglia following footpad inoculation of mice with herpes simplex virus type 1 mutant in1814
7. Famciclovir - Origins, progress and prospects
8. The effects of delayed-onset chemotherapy using famciclovir or valaciclovir in a murine immunosuppression model for HSV-1
9. Early therapy with valaciclovir or famciclovir reduces but does not abrogate herpes simplex virus neuronal latency
10. Comparison of efficacies of famciclovir and valaciclovir against herpes simplex virus type 1 in a murine immunosuppression model
11. Acyclic guanosine analogs inhibit DNA polymerases alpha, delta, and epsilon with very different potencies and have unique mechanisms of action
12. Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system
13. An analysis of herpes simplex virus gene expression during latency establishment and reactivation
14. The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation
15. Effects of ganciclovir, penciclovir and acyclovir on apoptosis
16. Two patterns of persistence of herpes simplex virus DNA sequences in the nervous systems of latently infected mice
17. Differential effects of famciclovir and valaciclovir on the pathogenesis of herpes simplex virus in a murine infection model including reactivation from latency
18. Comparison of effects of famciclovir and valaciclovir on pathogenesis of herpes simplex virus type 2 in a murine infection model
19. The influence of cyclosporin immunosuppression on the efficacy of famciclovir or valaciclovir chemotherapy studied in a murine herpes simplex virus type 1 infection model
20. Famciclovir and valaciclovir differ in the prevention of herpes simplex virus type 1 latency in mice: A quantitative study
21. Persistence of infectious herpes simplex virus type 2 in the nervous system in mice after antiviral chemotherapy
22. Further evidence from a murine infection model that famciclovir interferes with the establishment of HSV-1 latent infections
23. + transfectants of Chinese hamster ovary cells
24. Mode of action of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cells